213 related articles for article (PubMed ID: 12434585)
1. Bases for a spinal analgesic action of cyclooxygenase inhibitors.
Vanegas H
Proc West Pharmacol Soc; 2002; 45():225-7. PubMed ID: 12434585
[No Abstract] [Full Text] [Related]
2. [Cyclooxygenases in the spinal cord and the relationship with pain].
Li SQ; Li WB
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):359-60. PubMed ID: 14992024
[No Abstract] [Full Text] [Related]
3. COX in a crystal ball: current status and future promise of prostaglandin research.
FitzGerald GA; Loll P
J Clin Invest; 2001 Jun; 107(11):1335-7. PubMed ID: 11390412
[No Abstract] [Full Text] [Related]
4. [Progress in the study of cyclooxygenase].
Zhu H; Yang ZM
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):81-3. PubMed ID: 15127608
[No Abstract] [Full Text] [Related]
5. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
Patrignani P
Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
[No Abstract] [Full Text] [Related]
6. The development of COX2 inhibitors.
Flower RJ
Nat Rev Drug Discov; 2003 Mar; 2(3):179-91. PubMed ID: 12612644
[TBL] [Abstract][Full Text] [Related]
7. [COX-2 inhibitors: current status and outlook].
Dannhardt G; Hahn L
Pharm Unserer Zeit; 2000 Mar; 29(2):100-6. PubMed ID: 10763335
[No Abstract] [Full Text] [Related]
8. Mechanism of action of anti-inflammatory drugs.
Vane JR; Botting RM
Adv Exp Med Biol; 1997; 433():131-8. PubMed ID: 9561120
[No Abstract] [Full Text] [Related]
9. [A heterogenous drug class. NSAID: classification and spectrum of action].
Ulbrich H; Dannhardt G
Pharm Unserer Zeit; 2002; 31(2):146-54. PubMed ID: 11977450
[No Abstract] [Full Text] [Related]
10. Spinal synthesis and release of prostanoids after peripheral injury and inflammation.
Dirig DM; Yaksh TL
Adv Exp Med Biol; 1999; 469():401-8. PubMed ID: 10667359
[No Abstract] [Full Text] [Related]
11. [How do aspirin and company work? Cyclooxygenases--point of attack of nonsteroidal antirheumatics].
Steinhilber D
Pharm Unserer Zeit; 2002; 31(2):140-4. PubMed ID: 11977449
[No Abstract] [Full Text] [Related]
12. Regulation of cyclo-oxygenase-2.
Stack E; DuBois RN
Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):787-800. PubMed ID: 11566041
[TBL] [Abstract][Full Text] [Related]
13. Effects of natural products containing acylresorcinol partial structures on cyclooxygenases and 5-lipoxygenase.
Bracher F; Krauss J; Laufer S
Pharmazie; 2001 May; 56(5):430. PubMed ID: 11400568
[No Abstract] [Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs increase expression of inducible COX-2 isoform of cyclooxygenase in spinal cord of rats with adjuvant induced inflammation.
Hsueh SF; Lu CY; Chao CS; Tan PH; Huang YW; Hsieh SW; Hsiao HT; Chung NC; Lin SH; Huang PL; Lyu PC; Yang LC
Brain Res Mol Brain Res; 2004 Jun; 125(1-2):113-9. PubMed ID: 15193428
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of COX2 inhibitors questioned.
Petit-Zeman S
Nat Rev Drug Discov; 2004 Sep; 3(9):726-7. PubMed ID: 15368654
[No Abstract] [Full Text] [Related]
16. [Progress in the therapy of rheumatism].
Heinzl S
Med Monatsschr Pharm; 1999 Aug; 22(8):225. PubMed ID: 10481432
[No Abstract] [Full Text] [Related]
17. Thalidomide, cyclooxygenase-2, and angiogenesis: potential for therapy.
Onn A; Tseng JE; Herbst RS
Clin Cancer Res; 2001 Nov; 7(11):3311-3. PubMed ID: 11705841
[No Abstract] [Full Text] [Related]
18. Cyclooxygenase (COX) inhibitors: a comparative QSAR study.
Garg R; Kurup A; Mekapati SB; Hansch C
Chem Rev; 2003 Mar; 103(3):703-32. PubMed ID: 12630850
[No Abstract] [Full Text] [Related]
19. Cyclooxygenase-2 inhibitors: promise or peril?
Mengle-Gaw LJ; Schwartz BD
Mediators Inflamm; 2002 Oct; 11(5):275-86. PubMed ID: 12467519
[TBL] [Abstract][Full Text] [Related]
20. Cloning, expression, and selective inhibition of canine cyclooxygenase-1 and cyclooxygenase-2.
Gierse JK; Staten NR; Casperson GF; Koboldt CM; Trigg JS; Reitz BA; Pierce JL; Seibert K
Vet Ther; 2002; 3(3):270-80. PubMed ID: 12447834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]